tiprankstipranks

Daniel Faga Insider Profile

4 Followers
Daniel Faga, CBO at Spark Therapeutics, holds 401.65K shares in AnaptysBio (Ticker: ANAB), holds 30.64K shares in Mirati Therapeutics (Ticker: MRTX), holds 0.00 shares in Spark Therapeutics (Ticker: ONCE). Most recently, Daniel Faga Sold ― shares of AnaptysBio on Mar 26, 2024 for an estimated value of 10.89M.
tipranks
Daniel Faga

Daniel Faga
Spark Therapeutics (ONCE)
CBO

Ranked #40,201 out of 99,635 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

+17.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$10M
100.00%
A breakdown of Daniel Faga's holdings

Insider Roles

AnaptysBio
(ANAB)
CEO, Director
Roles that Daniel Faga holds in companies

Most Profitable Insider Trade

Stock:
Mirati Therapeutics
(MRTX)
Rating:Informative Sell
Date:Jan 08, 2021 - Jan 08, 2022
Return:+39.00%
The most profitable trade made by Daniel Faga

Daniel Faga's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ONCE
Spark Therapeutics
Dec 17, 2019
Uninformative Sell
4.45M
$0.00
MRTX
Mirati Therapeutics
Jan 20, 2021
Uninformative Buy
$1.80M
AnaptysBio
Mar 26, 2024
CEO, Director
Informative Sell
10.89M
$9.68M
List of latest transactions for each holding click on a transaction to see Daniel Faga's performance on stock

Daniel Faga insider profile FAQ

What is the percentage of profitable transactions made by Daniel Faga?
The percentage of profitable transactions made by Daniel Faga is 50%.
    What is the average return per transaction made by Daniel Faga?
    The average return per transaction made by Daniel Faga is 17.90%.
      What stocks does Daniel Faga hold?
      Daniel Faga holds: ONCE, MRTX, ANAB stocks.
        What was Daniel Faga’s latest transaction?
        Daniel Faga latest transaction was an Informative Sell of $10.89M.
          What was Daniel Faga's most profitable transaction?
          Daniel Faga’s most profitable transaction was an Informative Sell of MRTX stock on January 8, 2021. The return on the trade was 39.00%.
            What is Daniel Faga's role in Spark Therapeutics?
            Daniel Faga's role in Spark Therapeutics is CBO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.